Insider Transactions in Q2 2025 at Aclaris Therapeutics, Inc. (ACRS)

ACRS Quotes by TradingView

Insider Transaction List (Q2 2025)

Date Insider Transaction Ownership Type Shares Traded Value / Price
Apr 01 2025
Neal Walker CEO
SELL
Payment of exercise price or tax liability
Direct
3,042 -0.21%
$3,042 $1.48 P/Share
Apr 01 2025
Neal Walker CEO
BUY
Exercise of conversion of derivative security
Direct
9,467 +0.64%
-

Track Institutional and Insider Activities on ACRS

Follow Aclaris Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACRS shares.

Notify only if

Insider Trading

Get notified when an Aclaris Therapeutics, Inc. insider buys or sells ACRS shares.

Notify only if

News

Receive news related to Aclaris Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ACRS